Open AccessClinical Features and Short-Term Outcomes of Bariatric Surgery in Morbidly Obese Patients: Institutional Experience at a Rural Hospital
Author(s) -
Kazım Şenol,
Murat Ferhat Ferhatoğlu,
Ayşen Akkurt Kocaeli,
Halit Ziya Dündar,
Ekrem Kaya
Publication year - 2021
Publication title -
bariatric surgical practice and patient care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.233
H-Index - 12
eISSN - 2168-0248
pISSN - 2168-023X
DOI - 10.1089/bari.2020.0110
Subject(s) - medicine , weight loss , body mass index , comorbidity , obstructive sleep apnea , surgery , diabetes mellitus , mortality rate , obesity , endocrinology
Objective: To prospectively evaluate the postoperative morbidity, mortality, and weight loss evolution of patients who underwent a bariatric procedure during 1 year of follow-up. Methods: Since July 2016, a total of 101 patients' data have been prospectively registered in a database. Comorbidities, operating time, hospital stay, early and late complications rate, and weight loss evolution after 1 year of follow-up were recorded. Results: The mean age was 38.41 ± 11.05 years with a mean body mass index (BMI) of 49.02 ± 5.89 kg/m 2 (range 38-67). Laparoscopic sleeve gastrectomy (LSG) was performed in 93 patients (92.07%) and Roux-en-Y gastric bypass (RNYGB) in 8 patients (7.92%). Thirty-day morbidity rate was 7.92% (8/101). Within a mean 9.32 ± 2.25 (range 1-19) months follow-up time, mean percent of the excess of weight loss of 1st, 6th, and 12th months were 22.7 ± 6.1, 67.2 ± 11.2, and 81.4 ± 10.5, respectively. Diabetes ( n = 38, 37.6%), hypertension ( n = 13, 12.9%), and obstructive sleep apnea ( n = 5, 4.9%) were resolved in 76%, 68.4%, and 100% of the patients, respectively ( p < 0.001). Conclusions: LSG and RNYGB are safe and highly effective, particularly in patients with a BMI >50 kg/m 2 . Both techniques have been presented with better clinical outcomes regarding significant comorbidity resolution in the early evolution of weight loss.